INS and polycystic ovary syndrome: Reduced plasma mI concentrations have been reported in insulin-resistant states, including obesity and polycystic ovary syndrome, and mI supplementation has been shown to improve insulin sensitivity and metabolic parameters in these conditions [114,115].